What Cancer
Can and Can't do
NEWS
Hearst investment to aid cancer research
Wednesday, September 20, 201 San Francisco Chronicle By Chris Bosak NEW YORK — Hearst announced on Wednesday a $75 million equity inve ...more
Cancer Treatment Can Affect Your Food Preferences
TUESDAY, Sept. 19, 2017 (HealthDay News) -- Cancer therapies often change patients' sense of taste, which may affect what they like to eat, ...more
Aliqopa Approved for Follicular Lymphoma
THURSDAY, Sept. 14, 2017 (HealthDay News) -- Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults ...more
View All 
Events Back
Wednesday, July 26, 2017  to   Wednesday, July 26, 2017
Clinical Advances in Immunotherapy in Myeloma: Monoclonal Antibodies
Webinar - 1pm
Join us for the first in our series of 3 FREE webinars for patients and caregivers that describe the newest developments in the field of immuno-oncology in multiple myeloma.
It’s been said that “The best defense is a good offense”. This is true of the body’s ability to fight invaders, as our immune system has evolved sophisticated weapons to defeat and kill threats like bacteria, viruses, and cancer cells. Unfortunately, invading cancer cells have developed smart ways of hiding from the body’s own defenses. Luckily, researchers have recently discovered ways to overcome some of these mechanisms, and new immune therapies can now improve the body’s ability to defend itself against cancer.

Immuno-oncology is a new and rapidly growing therapeutic approach in cancer, and in multiple myeloma in particular. This webinar series will describe how the immune system normally functions to protect the body and will highlight how new immune therapies such as

• Monoclonal antibodies
• Cancer vaccines
• Engineered immune cells

can be effective treatments for multiple myeloma patients. Faculty will discuss current therapeutic advances, their successes as well as failures, and will describe the future promise of these new therapeutics as part of the multiple myeloma drug arsenal. This information will help multiple myeloma patients and caregivers talk to their care teams about these therapeutic choices and together decide if one of these new immune treatments might be appropriate for them.


Webinar 2: Myeloma Vaccines
Wednesday, July 26, 2017 – 1:00PM ET
Presenting Faculty:
David Avigan, MD – Beth Israel Deaconess Medical Center

Register at http://eventcallregistration.com/reg/index.jsp?cid=70442t11pk
facebook